trending Market Intelligence /marketintelligence/en/news-insights/trending/ob8pwmnk3grbw5d2bs2foq2 content esgSubNav
In This List

Verastem Oncology begins $35M common stock offering

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Verastem Oncology begins $35M common stock offering

Verastem Inc. commenced a public offering of its common stock worth $35 million.

The Needham, Mass.-based biopharmaceutical company granted the underwriter an option to buy up to an additional $5.25 million worth of common shares.

Cantor Fitzgerald & Co. is acting as sole book-running manager for the offering.